Introduction {#S1}
============

Borderline personality disorder (BPD) is a psychiatric condition characterized by three symptom clusters including affective dysregulation, impulsivity, and disturbed relatedness ([@B53]). According to the mentalization-based model of BPD ([@B57]; [@B26]), these features of BPD can be viewed as a consequence of impairments in the capacity to mentalize, i.e., to understand behavior in terms of underlying mental states. According to this theory, mentalization is defined as a multidimensional construct involving several dimensions and abilities. One of these dimensions relates to the objects of mentalizing: it can be directed either toward the mental states of the self or toward the mental states of others.

Impairment of self-oriented mentalizing can be manifested as low levels of emotional self-awareness or alexithymia ([@B13]). Alexithymia is a clinical condition characterized by an inability to identify and describe one's own affective experiences ([@B63]). Studies have found that borderline patients are more alexithymic than healthy controls (for a meta-analysis, see [@B16]) and reported relationships between BPD individuals' alexithymic traits and the severity of their symptoms (e.g., [@B28]; [@B42]). However, to date, no attention has been paid to the potential neurocognitive underpinnings of alexithymia in BPD.

Other-oriented mentalizing can be operationalized as theory of mind (ToM) ([@B13]), a social cognitive function by which we can attribute mental states, such as beliefs, intentions, and emotions, to others ([@B6]). ToM is a multidimensional construct and consists of several subprocesses ([@B61]; [@B52]). Mental state decoding is the social--perceptual aspect of ToM, which involves the ability to detect and discriminate others' mental states based on their observable social behavior. Mental state reasoning implies the social--cognitive subcomponent, involving causal inferences and predictions about others' mental states based on additional information sources including context and general social knowledge.

Findings on ToM performance in BPD indicate that the decoding and reasoning subprocesses of ToM may be unequally affected by the disorder. Several studies have found that BPD patients exhibited intact or even enhanced ability to decode others' mental states based on facial expressions ([@B20]; [@B27]; [@B73]). By contrast, other studies have shown that borderline patients perform worse than healthy controls on ToM reasoning tasks ([@B31]; [@B11]), but the severity of their deficit is task dependent ([@B46]). It has been suggested that BPD patients' ToM impairment becomes apparent in more complex tasks that require contextual processing and the integration of multiple mental state perspectives ([@B4]; [@B46]). This raises the possibility that the difficulties of BPD patients in ToM reasoning are not due to deficits in their basic ToM abilities but rather to deficits in neurocognitive skills, mainly in executive functioning.

Executive functioning (EF) refers to capabilities that enable flexible and goal-directed responses in novel or complex situations. Through the higher-order monitoring and regulation of cognitive subprocesses, EF plays an important role in the operation of many cognitive functions ([@B12]). The role of EF in mentalizing abilities is a widely investigated topic in both clinical and non-clinical samples. Regarding emotional awareness, it has been hypothesized that the cognitive systems that are responsible for the higher-level elaboration of emotional experiences are not specialized for emotional processing but rather implement domain-general executive functions ([@B39]; [@B38]). This notion implies that executive dysfunction may cause disturbances in emotional self-awareness. Supporting this idea, several studies have found a relationship between poor performance on EF tasks and alexithymic symptoms (e.g., [@B32]; [@B54]).

Concerning the EF--ToM relationship, it has been suggested that these two abilities are implemented by two separate but interacting cognitive systems ([@B59]; [@B1]; [@B71]). According to this view, there are cognitive mechanisms specifically involved in the representation of mental states, but domain-general executive processes are required to efficiently manage and properly apply those representations in complex circumstances. In line with this assumption, many behavioral studies have demonstrated that performance on EF tests shows association with ToM performance, mainly in the case of those complex ToM tasks that have high cognitive load and contextual demands ([@B1]; [@B2]). These results suggest that EF is more strongly related to the reasoning aspect of ToM than to the decoding component.

There is a lack of research on the relationship between mentalizing abilities and EF in BPD. This limitation is particularly striking in studies that have demonstrated structural and functional abnormalities in frontal executive brain areas and impaired behavioral performance on executive tasks in borderline patients ([@B37]; [@B41]). Given this gap in the literature, the present study addressed two objectives. The first aim was to analyze simultaneously the mentalizing and executive profiles of BPD patients by comparing their performance to healthy individuals on tasks assessing different subdomains of mentalization and EF. Our second aim was to perform multivariate analyses to determine the relative importance of BPD diagnosis and EF in predicting alexithymia, as well as ToM performance while considering the potential effects of psychiatric symptom severity and general intelligence.

Methods {#S2}
=======

Participants {#S2.SS1}
------------

BPD patients (*N* = 18) were recruited from the Affective Disorder Unit of the Department of Psychiatry and Psychotherapy, University of Pécs. All patients fulfilled the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) diagnostic criteria for BPD ([@B3]). Exclusion criteria for the patient group were any other personality disorder, psychotic disorders, bipolar disorder, posttraumatic stress disorder, current substance use disorder, a history of head injury, neurological diseases, and intellectual disability. Healthy controls (HC, *N* = 18) were recruited through online advertisements. Exclusion criteria for controls included any mental disorder, a history of substance abuse, a history of neurological disorders, and head injury with loss of consciousness for more than 30 min, an IQ \< 85, and any learning difficulties. All participants lived in the urban and suburban area of Pécs, were Caucasian, and native Hungarian speakers.

The diagnoses were established with structured clinical interviews (SCID-5-CV: [@B23]; SCID-5-PD: [@B22]). The severity of psychiatric symptoms was assessed with the Symptom Check List-90-Revised (SCL-90-R) questionnaire ([@B17]; [@B67]), and the overall level of intelligence (IQ) was estimated with a four-subtest version of the Wechsler Adult Intelligence Scale-Revised ([@B35]). At the time of the investigations, 17 of the 18 patients were on psychotropic medication. Healthy controls were matched pairwise to the patients for sex, age (±4 years), education (±2 years), and IQ (±5 points). None of the healthy individuals took psychotropic medication. The clinical and demographic data are presented in [Table 1](#T1){ref-type="table"}.

###### 

Demographic and clinical characteristics of the study samples.

                                         BPD (*n* = 18)   HC (*n* = 18)   *t*-value   *P*-value                     
  -------------------------------------- ---------------- --------------- ----------- ------------- --------------- ---------------
  **Demographics**                                                                                                  
  Gender ratio (female/male)             17/1             17/1                                                      
  Age in years (mean ± SD)               34.72 ± 8.02     34.11 ± 9.39    0.210       0.835                         
  Education level in years (mean ± SD)   12.78 ± 3.30     12.89 ± 2.78    --0.240     0.812                         
  IQ estimate (mean ± SD)                109.79 ± 8.22    112.99 ± 8.60   --1.139     0.262                         
  **Psychiatric symptom severity**                                                                                  
  SCL-90-R GSI (mean ± SD)               2.06 ± 0.66      0.40 ± 0.28     9.769       **\<0.001**                   
  SCL-90-R PST (mean ± SD)               66.94 ± 12.24    23.22 ± 12.42   10.639      **\<0.001**                   
  SCL-90-R PSDI (mean ± SD)              2.71 ± 0.47      1.48 ± 0.54     7.210       **\<0.001**                   
                                                                                                                    
                                         ***n***          **%**           ***n***     **%**         **Chisquare**   ***P*-value**
                                                                                                                    
  **Current comorbid disorders**                                                                                    
  Depressive disorders                   10               55.5            0           0             13.85           **\<0.001**
  Anxiety disorders                      6                33.3            0           0             7.2             **\<0.01**
  Substance use disorders                5                27.7            0           0             5.81            **0.016**
  Eating disorders                       1                5.5             0           0             1.014           **0.31**
  **Medications**                                                                                                   
  Antidepressants                        11               61.1                                                      
  Benzodiazepines                        13               72.2                                                      
  Mood stabilizers                       9                50                                                        
  Antipsychotics                         16               88.8                                                      

Statistically significant

P

-values are written in bold. BPD, borderline personality disorder; HC, healthy controls; IQ, intelligence quotient; SCL-90-R, Symptom Check List-90-Revised; GSI, Global Severity Index; PST, Positive Symptom Total; PSDI, Positive Symptom Distress Index; SD, standard deviation.

All subjects gave written informed consent, and the study was approved by the Research Ethics Committee of the Faculty of Humanities, University of Pécs (Ethical Approval No.: 2015/1).

Instruments {#S2.SS2}
-----------

### Executive Function Tasks {#S2.SS2.SSS1}

Four subdomains of executive functioning (EF) were measured: (1) mental set shifting \[with Wisconsin Card Sorting Test (WCST); [@B8]\]; (2) working memory updating \[with Listening Span Task (LST); [@B15]; [@B34]\]; (3) prepotent response inhibition \[with Eriksen Flanker Task (FT); [@B18]\]; and (4) long-term memory access \[with the Letter Fluency Task (LFT); see [@B60]; [@B62]\]. The WCST and the FT were computerized tasks taken from the Psychology Experiment Building Language (PEBL) test battery ([@B44]). The EF variables of interest were the number of perseverative errors on the WCST, the number of words remembered in the LST, the interference time on the FT, and the number of words generated in the LFT. To get a global measure of executive functioning, we calculated an average *z* score from these four EF variables, which was converted into a *t* score (= composite EF score).

### Mentalizing Tests {#S2.SS2.SSS2}

The level of emotional self-awareness/alexithymia was surveyed using the total scores of the 20-item self-report Toronto Alexithymia Scale (TAS-20; [@B5]; [@B14]).

ToM capacities were examined with two standard ToM tasks. To measure ToM decoding ability, we used the Reading the Mind in the Eyes Test (RMET, [@B7]; [@B33]). This task is composed of 36 black-and-white photographs depicting the eye region. For each photograph, four mental state words were displayed, and the participants' task was to decide which one best described what the person in the picture was feeling or thinking. As the RMET requires recognition of others' mental states based on static and socially decontextualized perceptual stimuli, it does not necessitate contextual processing and complex inferences about mental states. Thus, the RMET is regarded as a prototypical task to measure the social--perceptual, decoding aspect of ToM ([@B52]; [@B10]; [@B50]).

ToM reasoning was assessed with the Faux Pas Test (FPT, [@B58]; [@B29], [@B30]). This task consists of 20 short stories about different interpersonal situations that may or may not contain a social faux pas. After each story, participants were asked whether any of the story characters said something awkward. If participants said yes, further questions were raised regarding the characters' cognitive and affective mental states. As a story-based verbal task, the FPT does not involve perceptual processing and requires causal inferences about the characters' mental states on the basis of information provided by the contextual scenes and general social knowledge. Based on these features, the FPT is regarded as an appropriate task to investigate the social--cognitive, reasoning aspect of ToM ([@B72]; [@B64]; [@B19]). (Detailed information about tests used in the study is reported in the [Supplementary Material](#TS1){ref-type="supplementary-material"}).

Statistical Analysis {#S2.SS3}
--------------------

Between-group differences in demographic, clinical, neuropsychological, alexithymia, and ToM variables were analyzed using independent-samples *t* tests. For EF and mentalizing measures, we calculated Cohen's *d* effect sizes. After the between-group comparisons, assumptions were tested, and multiple linear regression analyses were run in the whole sample. In the regression models, the total scores of TAS-20, RMET, and FPT were separately taken as dependent variables. BPD diagnosis (coded as a dummy variable: 0 = absence of the diagnosis, 1 = presence of diagnosis), SCL-90-R Global Severity Index (GSI), estimated IQ, as well as the composite EF scores were used as predictors in all models. To estimate the effect sizes of the predictors, Cohen's *f*^2^ values were calculated. *P*-values (two-tailed) ≤ 0.05 were considered statistically significant.

Results {#S3}
=======

Between-Group Comparisons {#S3.SS1}
-------------------------

The demographic and clinical features of BPD and HC groups are shown in [Table 1](#T1){ref-type="table"}. The groups were matched in terms of gender, age, education level, and estimated IQ. On the SCL-90-R questionnaire, the BPD group had significantly higher depression, anxiety, and global severity scores than the controls.

Group means and results of between-group comparisons for EF and mentalizing performances are presented in [Table 2](#T2){ref-type="table"}. There were no significant between-group differences in any EF domains. (We found a medium effect size for the composite EF and Inhibition scores, with a trend level significance of between-group difference for the latter one).

###### 

Executive functions and mentalizing abilities in patients with borderline personality disorder (BPD) and healthy control (HC).

                                            BPD (*n* = 18)   HC (*n* = 18)   *t*-value   *P*-value   Cohen's *d*                   
  ----------------------------------------- ---------------- --------------- ----------- ----------- ------------- --------------- -----------
  **Executive functions**                                                                                                          
  Shifting (WCST perseverative errors)^a^   10.61            5.20            8.78        4.91        1.088         0.284           0.36
  Updating (LST working memory span)        3.37             0.68            3.65        0.89        --1.046       0.303           --0.35
  Inhibition (FT interference time)^a^      43.85            23.74           29.17       25.17       1.800         0.081           0.60
  Access (LFT total words)                  50.39            15.21           51.78       16.44       --0.263       0.794           --0.09
  Composite executive function score        46.62            6.76            50.00       5.65        --1.629       0.113           --0.54
  **Mentalizing**                                                                                                                  
  Alexithymia (TAS-20 total score)^a^       59.00            12.78           43.67       10.48       3.936         \<**0.001\***   **1.31**
  ToM decoding (RMET total score)           24.67            4.17            25.56       2.77        --0.753       0.457           --0.25
  ToM reasoning (FPT total score)           27.78            5.94            31.89       4.55        --2.332       **0.026**       **−0.78**

Group means and between-group comparisons. BPD, borderline personality disorder; HC, healthy controls; WCST, Wisconsin Card Sorting Test; LST, Listening Span Task; FT, Flanker Task; LFT, Letter Fluency Task; TAS-20, Toronto Alexithymia Scale-20 items; RMET, Reading the Mind in the Eyes Test; FPT; Faux Pas Test; SD, standard deviation.

a

Higher scores indicate worse functioning. Statistically significant results are presented in bold. \*Significant after Bonferroni correction. Cohen's

d

values of 0.2, 0.5, and 0.8 represent small, medium, and large effect sizes, respectively.

### Mentalizing Abilities {#S3.SS1.SSS1}

The BPD group had a significantly higher alexithymia score on the TAS-20 relative to the HC group (*P* \< 0.001, Cohen's *d* = 1.31). In our sample, ToM decoding (RMET) performances in the two groups did not significantly differ. However, the BDP group showed a significant impairment in ToM reasoning (*P* = 0.026, Cohen's *d* = -0.78), as demonstrated by their lower mental state inference score on the FPT.

Regression Analyses in the Whole Sample {#S3.SS2}
---------------------------------------

### Alexithymia {#S3.SS2.SSS1}

The multiple regression model predicting alexithymia was significant, explaining 56.9% of the variance in the TAS-20 scores. The diagnosis of BPD, the estimated IQ, and the composite EF score were non-significant predictors with small-to-medium effect sizes. General psychiatric symptom severity was the only significant predictor in the model (*P* = 0.002, Cohen's *f*^2^ = 0.36) ([Table 3](#T3){ref-type="table"}).

###### 

Multiple regression models for mentalizing abilities.

  Variables                           *B*       Std. Error   Beta      *t*-value   *P*-value   Cohen's *f*^2^
  ----------------------------------- --------- ------------ --------- ----------- ----------- ----------------
  **Alexithymia^a^**                                                                           
  Constant                            73.288    26.942                 2.720       0.011       
  BPD diagnosis                       --5.479   6.694        --0.200   --0.818     0.419       −0.02
  Symptom severity                    12.797    3.805        0.904     3.363       **0.002**   **0.36**
  IQ estimate                         --0.308   0.233        --0.187   --1.322     0.196       −0.06
  Executive functioning               4.271     3.098        0.196     1.379       0.178       0.06
  **Theory of Mind decoding^b^**                                                               
  Constant                            25.170    8.749                  2.877       0.007       
  BPD diagnosis                       4.440     2.174        0.640     2.043       **0.050**   **0.14**
  Symptom severity                    --3.015   1.236        --0.841   --2.440     **0.021**   **−0.19**
  IQ estimate                         0.014     0.076        0.034     0.187       0.853       0.00
  Executive functioning               0.805     1.006        0.146     0.800       0.430       0.02
  **Theory of Mind reasoning^*c*^**                                                            
  Constant                            1.224     11.743                 0.104       0.918       
  BPD diagnosis                       --6.559   2.918        --0.592   --2.248     **0.032**   **−0.16**
  Symptom severity                    2.767     1.658        0.484     1.669       0.105       0.09
  IQ estimate                         0.262     0.101        0.394     2.577       **0.015**   **0.21**
  Executive functioning               3.895     1.350        0.442     2.885       **0.007**   **0.27**

Predictors of mentalizing abilities in the whole sample (

n

= 36). Cohen's

f

2

values of 0.02, 0.15, and 0.35 represent small, medium and large effect sizes, respectively. Statistically significant results are presented in bold. BPD, borderline personality disorder; IQ, intelligence quotient.

a

F

(4,31) = 10.24,

P

\< 0.001.

b

F

(4,31) = 3.19,

P

\< 0.026.

c

F

(4,31) = 7.70,

P

\< 0.001.

### ToM Decoding {#S3.SS2.SSS2}

The multiple regression model predicting ToM decoding accuracy was significant, accounting for 29.2% of the variance in the RMET scores. In this model, BPD diagnosis predicted significantly better performance on the RMET (*P* = 0.05, Cohen's *f*^2^ = 0.14). However, greater psychiatric symptom severity was related to significantly worse performance (*P* = 0.021; Cohen's *f*^2^ = -0.19). The cognitive variables and IQ were non-significant predictors with small effects ([Table 3](#T3){ref-type="table"}).

### ToM Reasoning {#S3.SS2.SSS3}

The multiple regression model predicting ToM reasoning ability was significant, with 49.8% of the variance in the FPT scores accounted for by the predictors. BPD diagnosis was a significant negative predictor of FPT performance (*P* = 0.032, Cohen's *f*^2^ = -0.16). Higher estimated IQ and composite EF scores predicted significantly better performance on the FP (*P* = 0.015, Cohen's *f*^2^ = 0.21, and *P* = 0.007, *f*^2^ = 0.27, respectively). Only the general symptom severity was a non-significant predictor in this model ([Table 3](#T3){ref-type="table"}).

Discussion {#S4}
==========

This is the first study to examine the relationship between EF, alexithymia, and ToM in BPD while simultaneously considering the confounding effects of psychiatric symptom severity and general IQ. Our results strengthen the notion that BPD patients' mentalizing subdomains are dissociated: their self-awareness and ToM reasoning were impaired, while their ToM decoding was comparable with those of healthy controls. In a series of multiple regression models, we tested the relative predictive value of EF, IQ, the comorbid clinical symptoms, and the diagnosis of BPD on mentalizing capacities. Comorbid psychiatric symptoms had significantly negative relative importance while predicting self-awareness/alexithymia and ToM decoding. However, the diagnosis of BPD was proved to be a significant negative predictor of ToM reasoning but a positive predictor of decoding. EF and IQ positively influenced BPD patients' ToM reasoning.

The Executive and Mentalizing Profile of BPD {#S4.SS1}
--------------------------------------------

For assessing EF, we adopted theories about the fractionation of EF into different subcomponents ([@B43]; [@B24]). There were no statistically significant between-group differences in any EF measures. However, BPD patients performed worse in the inhibition component of EF at a trend level significance (*P* = 0.081, with a medium effect size: Cohen's *d* = 0.6). This trend-level between-group difference is in harmony with prior studies suggesting that deficits in response inhibition may be of central importance in BPD ([@B48]; [@B49]; [@B51]; [@B69]; [@B66]). We can presume that the lack of significance was due to the low statistical power resulting from our small sample size.

Similarly to previous studies (for a review, see [@B16]), we found that BPD patients were significantly impaired relative to controls in their ability to mentalize (recognize and describe) their emotional states. Other-oriented mentalizing was operationalized in our study as ToM. The decoding and reasoning subcomponents of ToM were examined by prototypical tasks, the Reading the Mind in the Eyes Test, and the Faux Pas Test, respectively. Our results indicated that BPD patients' ability to decode others' mental states was preserved. By contrast, patients with BPD were impaired in their ability to reason about the mental states of others, evidenced by a large between-group difference in the number of correct mental state attributions on the Faux Pas Test. These findings replicated the results of several preceding studies and our recent meta-analysis that found similar performance on the RMET but substantially poorer performance on the Faux Pas Test in borderline patients compared to healthy controls ([@B4]; [@B46]; [@B73]; [@B45]). Our results endorse findings suggesting that the mentalizing profile in BPD is characterized by a dissociation between the decoding and the reasoning subprocesses of ToM.

Factors Influencing Mentalizing Abilities {#S4.SS2}
-----------------------------------------

In our multiple regression model, neither general IQ nor global executive functioning was a significant predictor of alexithymia. Interestingly, not the diagnosis of BPD, but greater severity of comorbid psychiatric symptoms has been proven to be a relative predictor of a higher TAS-20 score. These findings are in line with prior studies (e.g., [@B40]; [@B47]) demonstrating that borderline individuals are more alexithymic than healthy controls; however, this difference can mainly be explained by their comorbid clinical symptoms, especially by depression and anxiety. Although previous research has demonstrated a relationship between executive functioning and alexithymia in various clinical and non-clinical samples ([@B32]; [@B9]; [@B36]; [@B54]), our results suggest no relationship between these two abilities in BPD. Nevertheless, our study is the first that investigated this relationship in BPD; thus, further research with an extended number of cases is needed on this topic.

Remarkably, the multiple regression analysis predicting ToM decoding ability demonstrated opposing effects of BPD diagnosis and the severity of psychiatric symptoms. While BPD diagnosis predicted better performance on RMET, greater severity of coexisting psychiatric symptoms was associated with worse response accuracy. Previous studies using the RMET in borderline patients yielded inconsistent results, reporting reduced accuracy ([@B68]; [@B70]), enhanced accuracy ([@B20]; [@B73]), or no significant difference ([@B55]; [@B4]) compared to healthy controls. Our findings suggest that the inconsistency of prior studies may be at least partly due to the confounding effect of the severity of psychiatric symptoms.

We found that BPD diagnosis was independently related to worse reasoning performance on the FPT, while psychiatric symptom severity was not a significant predictor in the model. However, both higher general IQ and better global EF were independently related to higher FPT scores. Contrary to our RMET results, here, we found that better EF was related to improved FPT performance. These findings suggest that these two ToM tasks may rely on different mechanisms. With its decontextualized stimuli, the RMET does not require contextual processing and complex reasoning processes. The FPT is a verbal task and requires causal inferences about mental states based on short stories in real-life social contexts. In the FPT, adequate mental state attribution depends not only on the ability to extract relevant information from the context but also on the ability to integrate representations of the characters' mental states. Moreover, FPT also involves linguistic processing and other non-social cognitive skills and imposes additional cognitive load relative to the RMET. Our results suggest that this additional load uses up mainly executive function resources. These findings are in line with previous studies that examined the relationship between EF and ToM using RMET and FPT (e.g., [@B2]; [@B64]; [@B4]; [@B65]) and support the notion that the higher-order, reasoning aspect of ToM is more closely linked to domain-general cognitive abilities and prefrontal functioning than the lower-order, decoding component ([@B61]).

BPD diagnosis was also independently related to FPT performance in the multiple regression analysis. This negative effect of BPD remained significant in the model even after adjusting for general IQ, global EF, and psychiatric symptom severity. This suggests that mental state reasoning deficit might be a stable characteristic of the BPD. To date, only one study has examined the relationship between EF and ToM in BPD ([@B4]). Using similar ToM tasks, this research group found deficits both in EF and mental state reasoning in borderline patients. In their multivariate analysis, EF was significantly related to ToM reasoning performance, but BPD diagnosis was not a significant predictor of this ability, suggesting that mental state reasoning deficit is not a core feature of BPD, but is rather a consequence of executive dysfunction. Nevertheless, the small sample size is a major limitation for both studies; the contradictory relationship between EF and ToM in BPD deserves further examination.

Limitations {#S4.SS3}
-----------

The main limitation of our study was the low statistical power due to the small sample size. Thus, all of our findings must be treated as preliminary and should be replicated in larger samples. We should very carefully interpret our results especially those with EF. Executive dysfunction was suggested to play an important role in the pathomechanisms of BPD ([@B21]; [@B56]). A recent meta-analysis on neuropsychological functioning in BPD ([@B66]) found a moderate effect size (Cohen's *d* = -0.54) for EF impairment, which is the same as that on our composite EF scores. We can assume that our non-significant result in the between-group comparison of EF scores (*P* = 0.113) is largely due to the low number of cases.

Moreover, no clinical comparison group was included in the study; therefore, we did not investigate whether the detected mentalizing profile and its confounders are specific for BPD. BPD patients were recruited from the acute clinical setting. We did not examine demographic variables such as marital status and employment and did not follow-up on the sample to test how mentalizing abilities, cognitive functions, and comorbid clinical symptoms correlated with the demographic variables related to the functional outcome. Due to the high variability of comorbid psychiatric disorders and the psychotropic medications taken by BPD patients, it was not possible to form homogeneous subgroups to test the effect of these factors. Although a large proportion of our patients were on psychotropic medication (mainly on low-dose atypical antipsychotics), the impact of psychoactive drugs was not examined here. Finally, we only considered the severity of comorbid psychiatric symptoms measured by SCL-90; no other clinical questionnaires were applied.

Conclusion {#S5}
==========

Acknowledging the limitations, the present study provides some important clues for therapy and future research on mentalizing abilities in patients with BPD. Our study presents further evidence that there is a dissociation between ToM decoding and reasoning abilities in BPD. Our results fit well to the theory of [@B25]: BPD patients who grow up in a non-reflecting, non-validating, and often abusing family environment develop an increased emotional vigilance to social stimuli, especially to those with negative emotional content. Nevertheless, BPD patients' ToM abilities are just partially developed, since their reflexive awareness is low, and their mental state reasoning abilities are significantly impaired.

Based on our limited results, clinicians should carefully monitor BPD patients' comorbid psychiatric symptoms and consider that comorbid symptoms can negatively impact the patients' self-awareness and mental state decoding abilities. Conversely, impairment in mental state reasoning appears to be a core feature of BPD, but better IQ and EF can positively influence this deficit. However, regarding the low number of cases in our present study, further research is necessary to test our data in a larger sample.
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